FDA Inspection 1027896 — Arihiro Kiyosue
The FDA completed an inspection of Arihiro Kiyosue on Jun 2, 2017 in Chuo. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Jun 2, 2017
- Fiscal Year
- 2017
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Chuo (Japan)
Additional Details
Clinical Investigator (CI)